MINK THERAPEUTICS INC (INKT) Stock Income Statement
NASDAQ:INKT - Nasdaq - US6036932019 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.16M | 22.92M | 30.95M | 18.61M | 10.80M | |||
| Research and Development | 6.84M | 15.49M | 23.12M | 13.97M | 9.51M | |||
| Selling, General, and Administrative Expenses | 4.30M | 7.43M | 7.83M | 4.64M | 1.29M | |||
| Operating Income | -10.16M | -22.92M | -30.95M | -18.61M | -10.80M | |||
| Interest Income/Expense | 169.50K | 463.30K | 240.00K | -12.59M | -6.28M | |||
| Other Income/Expense | N/A | 0.00 | 2.72M | 630.00K | 840.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | 360.00K | N/A | |||
| Income Before Taxes | -9.74M | -22.46M | -27.99M | -30.21M | -16.24M | |||
| Net Income | -9.74M | -22.46M | -27.99M | -30.21M | -16.24M | |||
| EBITDA | -9.95M | -22.72M | -30.83M | -18.53M | -10.74M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.50 | -6.53 | -8.31 | -11.60 | -18.74 | |||
| Non GAAP EPS | -2.52 | -6.60 | -8.30 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD